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ABSTRACT 
The objective of the present study was to formulate effervescent and fast dispersible granules by incorporating the fruit extract of Emblica 
officinalis as an alternate of liquid herbal juices available in market. Amla juice was extracted manually and then subjected to preliminary 
phytochemical screening which indicates the presence of alkaloids, glycosides, flavonoids, carbohydrates, phenolic compounds,  proteins and 
phytosterols. Lyophilized amla powder was used to formulate effervescent and fast dispersible granules which were further opt imized on the 
basis of concentration of superdisintegrants and effervescent producing agents like croscarmellose sodium, sodium starch glycolate, sodium 
bicarbonate and citric acid. Powdered formulations were then evaluated on basis of their flow properties like angle of repose, bulk density, 
tapped density, carr’s index, hausner’s ratio, effervescent cessation time and disintegration time. Among all the effervescent formulations F2 
was found to be optimum as it was having least disintegration time of 22 seconds and showed excellent flow properties. In case of the fast 
dispersible formulations the optimum strength were shown by formulations F9 having croscarmellose with least disintegration time of 52 
seconds. Total phenolic content of fresh amla juice were found to be 8.94 mg GAE/100 gm and estimation of ascorbic acid and gallic acid in 
lyophilized amla powder and developed formulations was carried out by HPTLC. In vitro antioxidant activity of lyophilized amla powder was 
evaluated by DPPH radical scavenging assay. IC50 value of lyophilized amla powder was found to be 32 ± 0.25 ug/ml calculated in comparison to 
standard ascorbic acid possessing IC50 value of 25.80 ± 0.2 ug/ml.  Results of present study reveals that developed formulations may serve as 
alternate product with better quality, consistency and stability in comparison to available herbal liquid formulations.  
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Herbal juice has been used since the dawn of civilization to 
maintain health and to treat diseases. Use of herbal extracts 
in conventional medicinal system since antiquity and well 
established safety profile has resulted in wider acceptance 
by people. Inspite of wider acceptability there are some 
drawbacks related to herbal juices like stability, non-
uniformity in dose and portability etc so there is a need to 
design and develop a cost effective novel formulations, which 
give consistent product quality. The objective of the present 
study was to develop novel solid formulations by 
incorporating the fruit extract of amla as alternate of liquid 
herbal juices available in market. Fresh amla is so sour that 
most people find eating it almost intolerable so the 
portability and convenience of effervescent granules will 
dramatically increases patient compliance. Emblica officinalis 
commonly known as amla is considered as natural wonder 
drug. It is the richest source of vitamin C1. The drug also 
contains secondary metabolites viz. gallic acid, ellagic acid, 1-
O-galloyl-beta-D-glucose, 6-di-O-galloyl-D-glucose, quercetin, 
chebulinic acid, chebulagic acid, corilagin together with 
isostrictinnin2.  
The seeds of the Indian amla contain fixed oil, essential oil 
and phosphatides. The drug also contains secondary 
metabolites viz. gallic acid, ellagic acid, 1-O-galloyl-beta-D-
glucose, 6-di-O-galloyl-D-glucose, quercetin, chebulinic acid, 
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chebulagic acid, corilagin together with isostrictinnin2. The 
seeds of the Indian amla contain fixed oil, essential oil and 
phosphatides. The bark and leaves of amla are rich in 
tannins3. Traditionally it is used in treatment of dyspepsia, 
gout, ulcer, diarrhea, migraine4. It also possess antioxidant5, 
antidiabetic6, hepatoprotective, antitumor and anti-
inflammatory activity7.  
2. MATERIALS AND METHOD 
2.1 Plant material  
Amla fruits were procured from the local market of Moga 
(Punjab, India). The diseased, bruised and spotted fruits 
were sorted out. Healthy fruits were thoroughly washed in 
running tap water to remove dust and other extraneous 
materials. Plant herbarium was prepared and deposited in 
the Department of Quality Assurance, ISF College of 
Pharmacy for future reference.  
2.2 Preliminary study of amla 
In the preliminary study, various parameters for 
macroscopic and physical evaluation and composition of 
amla fruits have been studied.   
2.3 Preparation of amla juice 
Fruits were immediately pressed to obtain juice using a small 
laboratory manual press after cleaning and removal of seeds. 
Fine paste of extracted juice was made by placing pieces in a 
mixing jar. This paste was then wrapped into a lean cloth and 
squeezed with hand to get desire volume of amla juice. 
Organoleptic characters and yield of extracted juice was 
observed. 
2.4 Lyophilization of extracted amla juice 
The juice was first freeze dried at -20ºC for 12 h in deep 
freezer then lyophilized for next 8 hours consecutively for 3 
days until the extracts was converted into fine powder. 
Initial drying was carried out at -20ºC and final drying was 
carried out at -55 ºC8. The lyophilized powder was stored in 
an air tight container and kept in the desiccators until used. 
Organoleptic properties and yield of lyophilized amla juice 
was observed. 
2.5 Phytochemical screening  
The amla juice so obtained was subjected to preliminary 
phytochemical screening for the detection of various 
phytoconstituents. Various chemical reagents were used for 
the detection of alkaloids, glycosides, carbohydrates, sterols, 
phenolic compounds, tannins, flavonoids, saponins, proteins 
and amino acids9,10.  
2.6 Formulation and optimization of effervescent granules  
Herbal effervescent granules containing amla juice powder 
were prepared by wet granulation method. Specified 
quantities of citric acid (5-25%), tartaric acid (15 -35%) and 
sodium bicarbonate (20 -50%) were accurately weighed and 
triturated with lyophilized amla powder (5 gm) into fine 
particles. Sufficient quantity of binders was added along with 
10% PVP.   Ethanol and isopropyl alcohol (1:1) was added to 
make a damp mass. This mass was passed through sieve no. 
10 to get granules11,12. Granules were dried in hot air oven at 
40°C and packed in air tight container. Optimization of 
effervescent granules was carried out by varying 
concentration of all ingredients. 
2.7 Formulation and optimization of fast dispersible 
granules  
For the preparation of fast dispersible granules, the 
ingredients were mixed in a systematic manner. The 
superdisintegrants such as croscarmallose sodium, sodium 
starch glycolate and crospovidone in varying concentration 
(1-5%) were used to develop granules. The drug and 
excipients except lubricants were sieved through sieve no.10. 
Lubricants were passed through calibrated 100#mesh 
separately. The drug was then mixed with lubricants and 
passed through sieve no. 10 to prepare the granules. Wet 
granules were dried in hot air oven at 40ºC for 1 hour and 
stored in air tight container13,14. Optimization of fast 
dispersible granules was carried out by varying 
concentration of all ingredients.  
2.8 Evaluation of developed formulations  
The developed formulations were optimized and evaluated 
on the basis of their flow properties15,16. Parameters like 
angle of repose, bulk density, tapped density, carr’s index, 
hausner’s ratio, effervescent cessation time and dispersion 
time were evaluated and optimum formulation was 
selected17,18.  
2.8.1 Angle of repose 
The fixed funnel method was employed to measure the angle 
of repose. A funnel was secured with its tip at a given height 
(h), above a graph paper that is placed on a flat horizontal 
surface. The granules were carefully pored through the 
funnel until the apex of the conical pile just touches the tip of 
the funnel. The radius of the base of the conical pile was 
measured and angle of repose (Ѳ) was calculated by using 
the following formula: 
Tan θ = h/r, 
Where, θ = Angle of repose, h = Height of the cone, r = Radius 
of the cone base.  
2.8.2 Bulk density 
Granules (15 g) were introduced into a dry 100 ml cylinder, 
without compacting. The powder was carefully leveled 
without compacting and the unsettled apparent volume, VO, 
was read. The bulk density was calculated by using the 
following formula: 
ρb = M / Vo 
Where, ρb = Apparent bulk density, M = Weight of sample, Vo 
= Apparent volume of powder.   
2.8.3 Tapped density 
After carrying out the procedure as given in the 
measurement of bulk density, the cylinder containing the 
sample was tapped 500 times initially followed by an 
additional taps of 750 times until difference between 
succeeding measurement is less than 2% and then tapped 
volume, Vf was measured, to the nearest graduated unit. The 
tapped density was calculated, in gm per ml, using the 
following formula: 
ρtap = M / Vf 
Where, ρtap = Tapped density, M = Weight of sample, Vf = 
Tapped volume.  
2.8.4 Carr’s index 
These differences between the bulk and tapped densities are 
reflected in the Carr’s Index, which is calculated using the 
following formulas: 
Compressibility Index = [(ρtap - ρb) / ρtap] / ×100 
Where, ρb = Bulk density, ρtap = Tapped density. 
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2.8.5 Hausner’s ratio 
Hausner’s ratio is an indirect index of ease of powder flow. It 
is calculated as 
Hausner’s Ratio = Tapped density (ρt) / Bulk density (ρb) 
Where, ρt tapped density and ρb is bulk density.  
2.8.6 Effervescent cessation time 
One dose of effervescent granules (5g) was poured in beaker 
containing 100ml distilled water. Effervescent production 
was observed and effervescent cessation time was recorded 
for each formulation. 
2.8.7 Disintegration time of fast dispersible 
One dose of the dispersible granules (5g) was poured in a 
beaker containing 100 ml of distilled water and the time 
required for all the granules to completely 
disperse/disintegrate was recorded. 
2.9 Preparation of lyophilized amla powder sample 
One gm of amla juice powder was added to 10 ml of 
methanol and filtered. Volume was made upto 50 ml with 
methanol in volumetric flask. 
2.10 Estimation of total phenolic content in lyophilized 
amla powder  
Total phenolic contents in amla extract were determined by 
using Folin Ciocalteu’s reagent according to the modified 
method of Singleton and Rossi (1965). One ml aliquot of the 
sample was taken in a test tube and diluted with 10 ml of 
distilled water. Thereafter, 1.5 ml Folin Ciocalteu’s reagent 
(1:10) was added to each test tube and allowed to incubate 
at 25± 2°C for 5 minutes. Four ml of 20% (w/v) Na2CO3 were 
added to each test tube, adjusted with distilled water up to 
the mark of 25 ml and agitated. The quantification of total 
phenolics was assessed on the basis of gallic acid standard 
curve19,20. The absorbance of the resulting blue color in test 
was measured at 765 nm after 30 min (n=3). The results 
were expressed as percentage w/w. 
Total phenolic content (%w/w) = GAE×V×D×10-6×100/W 
GAE - Gallic acid equivalent (μg/ml) 
V – Total volume of sample (ml) 
D - Dilution factor 
W - Sample weight (gm) 
2.11 Estimation of ascorbic acid and Gallic acid  
2.11.1 Chemical and solvents 
Ascorbic acid and Gallic acid were purchased from Central 
Drug House Ltd. New Delhi, India.  Toluene, ethyl acetate, 
methanol, formic acid of analytical grade and precoated TLC 
silica gel 60 F254 aluminium plates (20 x10 cm, 0.2 mm thick)  
were procured from E. Merck. Germany. 
2.11.2 Instrumentation 
A HPTLC system (Camag, Switzerland) equipped with a 
sample applicator Linomat-V fitted with a 100 μl syringe 
(Hamilton, Switzerland), TLC Scanner III, Wincats 4.02, 
integration software (Camag, Switzerland) was used for the 
analysis and documentation. Analysis was performed by 
using TLC precoated silica gel 60 F254 aluminium plates (20 
x10 cm, 0.2 mm thick) as stationary phase. The linear 
ascending development was carried out in a twin trough 
glass chamber. 
 
2.11.3 Preparation of test samples 
About 10 mg of lyophilized amla juice powder was accurately 
weighed and transferred in a 20 ml volumetric flask 
containing 10 ml of methanol. The resultant solution was 
sonicated for 30 min at ultra sonicator. The solution filtered 
through 0.45 μ filter for the analytical purpose.  
2.11.4 Preparation of standard (Ascorbic acid and Gallic acid) 
A stock solution of 1mg/ml was prepared for the marker by 
dissolving accurately weighed 1 mg of standard (Ascorbic 
acid and Gallic acid) in 10 ml of methanol followed by 
sonication for 30 minutes at ultra sonicator. 
2.11.5 Sample application 
The samples were applied in the form of bands (8 mm width) 
with a Camag Linomat- V sample applicator on pre-coated 
silica gel TLC plate.  Application rate of 90nl/s was employed 
and space between the bands was 10 mm.  Linear ascending 
development was carried out in a twin trough glass chamber 
presaturated with mobile phase. Densitometry scanning was 
performed on TLC scanner III in the absorbance/reflectance 
mode.  
2.11.6 Estimation of ascorbic acid and gallic acid in lyophilized 
amla powder and in prepared formulation 
10 μl of test sample was applied on TLC plate with the help of 
sample applicator Linomat V and used for the quantification. 
The amount of ascorbic acid and gallic acid was determined 
by developing the chromatogram (10 μL spot−1) in triplicate 
by maintaining the chromatographic conditions21-23. 
Stationary Phase: Pre-coated silica gel aluminium plate 60, 
Mobile phase: Toulene: ethylacetate: methanol: formic acid 
(2:4:4:0.05 v/v/v), Sample: Test sample (10 μl), Standard: 
Ascorbic acid 1 mg/ml [5 μL], Gallic acid 1 mg/ml [5μL], 
Prechromatographic derivatization: 0.02 M Sodium acetate 
solution (w/v) Scanning wavelength: 488 nm. 
2.12 In vitro Evaluation of antioxidant activity  
The free radical scavenging activity of the fresh amla juice 
and lyophilized amla juice was determined by using in vitro 
assays such as DPPH assay. 
 
2.12.1 DPPH radical scavenging assay and determination of 
IC50 
The free radical scavenging activity of the fresh amla juice 
and lyophilized amla juice sample was determined by using 
in vitro assays i.e.  DPPH assay24. Extent of DPPH radical 
scavenged was determined by the decrease in intensity of 
violet color in the form of IC50 values.  
2.12.2 Sample preparation 
10 mg of powdered juice was weighed separately and 
dissolved in 10 ml of methanol to get 1000 µg/ml stock 
solutions. Lower concentrations (50, 100, 150, 200, 250 
µg/ml) were prepared by diluting serially with methanol for 
extract. 
2.12.3 Standard preparation 
10 mg of ascorbic acid was weighed accurately and dissolved 
in 10 ml of methanol to get 1000 µg/ml stock solutions. 
Lower concentrations (1, 2, 3, 4, 5 µg/ml) were prepared by 
diluting serially with methanol.  
2.12.4 Free radical scavenging activity (DPPH) 
The 0.1 mM solution of DPPH in methanol was freshly 
prepared. Different concentrations of fresh juice extract and 
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lyophilized sample (50, 100, 150, 200, 250 µg/ml) were 
added at an equal volume to methanolic solution of DPPH. 
After 30 min at room temperature, the absorbance was 
recorded at 517 nm. Ascorbic acid was used as standard 
control. Same procedure was followed to evaluate the 
scavenging activity of the lyophilized extracts25-31. All the 
tests were performed in triplicate and the scavenging activity 
of the extracts or standard was calculated as the percent 
inhibition of DPPH radical scavenged activity using the 
formula. 
                                            
                     
      
IC50 value was determined from the plotted graph of 
scavenging activity against the different concentrations of 
samples, and its fractions.  
3. RESULTS AND DISCUSSIONS:  
3.1 Preliminary study of amla 
Protein content, mineral composition and moisture content 
were preliminary evaluated in amla fruits. Composition and 
observation of various parameters for macroscopic and 
physical evaluation of amla fruit are summarized in Table 1 
and Table 2.   
3.2 Organoleptic studies and yield  
Organoleptic properties of extracted and lyophilized amla 
juice along with yield were recorded and summarized in 
Table 3. 
3.3 Amla juice preparation and lyophilization 
The amla juice was prepared and lyophilized successfully. 
The % yield of the juice and lyophilized powder were 
700ml/kg and 5.7gm/100ml respectively. 




Fat 0.1 % 





Iron 1.2 mg/100g 
Vitamin C 600 mg/100g 
 
Table 2. Macroscopic evaluation  of amla fruits 
Parameters Observations 
Fruit Shape Globular 
Size of the fruits  3.8 cm 
Fruit weight 41.24 – 52.48 g 
Fruit color  Greenish  yellow 
Special features Segmented through six ridges 
Pulp weight 91% of the fruit wt 
Ph 3.1-3.4 
Odour Characteristic 
Taste Astringent and sour 
 
Table 3. Organoleptic properties and yield of lyophilized 







Color Light green Greenish yellow 
Odor Characteristics Characteristics 
Taste Astringent, Sour Astringent ,Sour 
Yield 700 ml/Kg 8.5 gm (± 0.5) per 
200 ml 
 
3.4 Preliminary Phytochemical Screening 
The amla juice obtained was subjected to investigation for 
various phytoconstituents. It revealed the presence of 
different phytoconstituents like alkaloids, carbohydrates, 
glycosides, phenolics, protein, amino acid and phytosterols 
as in Table 4. 
Table 4. Phytochemical screening of fresh amla juice 
Constituents test reagents Observation 
Alkaloids 
Hager’s reagent + 
Wagner’s reagent + 
Mayer’s reagent + 
Carbohydrates 
Molisch’s reagent + 
Fehling’s reagent + 
Bendict’s reagent + 
Glycosides 
Legal’s test + 
Flavonoids 
Libermann test + 
Fixed oils 
Saponification test - 
Spot test        - 
Proteins and amino acids 
Millon’s reagent           + 
Biuret test           + 
Ninhydrin test           + 
Phenolics 
FeCl3 Solution           + 
Gelatin test           + 
Saponins 
Foam test             - 
Phytosterols 
Libermann test           + 
Salkowski test           + 
 
3.5 Formulation development and optimization of 
effervescent granules 
Herbal effervescent granules were prepared by wet 
granulation method. Citric acid (11.78g), tartaric acid 
(23.56g), sodium bicarbonate (40.05g) and amla powder 
(24.6g) were triturated into fine powder.  Then sufficient 
alcohol was added to make a damp mass. This mass was 
passed through sieve no. 10 to get granules. Total six 
formulations of effervescent granules were developed as 
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Table 5. Formulations of effervescent granules 
Ingredients 
(gm) 
Formulations code (Batches) 
F1 F2 F3 F4 F5 F6 
Amla  powder 5 5 5 5 5 5 
Citric  acid 1.1 2.3 4.1 4.8 5.8 6.6 
Tartaric acid 4.8 4.7 3.5 4.6 5.2 7.0 
Sodium bicarbonate 8.1 7.8 6.6 9.3 11.
2 
14 
Ethanol:IPA 1:1 1:1 1:1 1:1 1:1 1:1 
Binder (% ) 
(q.s) 
10 10 10 10 10 10 
 
 
3.6 Formulation and optimization of fast dispersible 
granules  
The super disintegrants (Croscarmallose sodium, sodium 
starch glycolate and crospovidone) in varying concentration 
(1-5%) were used to develop different formulations by wet 
granulation method as shown in Table 6-8. 
Table 6. Formulation of fast dispersible granules using 
crospovidone 
Ingredients (gm) Formulations code (Batches) 
F1 F2 F3 
Amla powder 5 5 5 
Crospovidone 1 2 3 
Microcrystalline 
cellulose 
10 10 10 
Lactose 20 20 20 
Binder (q.s) 10% 10% 10% 
Cardamom flavor QS QS QS 
 
Table 7. Formulation of fast dispersible granules using 
sodium starch glycolate 
Ingredients (gm) Formulations code 
(Batches) 
F4 F5 F6 
Amla powder 5 5 5 
Sodium starch glycolate 1 2 3 
Microcrystalline cellulose 10 10 10 
Lactose 20 20 20 
Binder (q.s) 10% 10% 10% 
Cardamom flavor QS QS QS 
 
Table 8. Formulation of fast dissolving granules using 
croscarmellose sodium 
Ingredients (gm) Formulations code 
(Batches) 
F7 F8 F9 
Amla powder 5 5 5 
Croscarmellose sodium 1 2 3 
Microcrystalline cellulose 10 10 10 
Lactose 20 20 20 
Binder (q.s) 10% 10% 10% 
Cardamom flavor QS QS QS 
 
3.7 Evaluation parameters of effervescent formulation  
3.7.1 Flow ability  
Bulk density, tapped density , angle of repose hausner’s ratio 
and carr’s index of the prepared formulations were 
evaluated for their flow properties. . The angle of repose of 
F2 effervescent formulation was in the range of 24.5°, which 
indicated   good flow of granules; the carr’s index was found 
to be in the range of 9.6 indicating good compressibility of 
granules. Hausner’s ratio was found to be in the range of 
1.137-1.25 and     indicative of good flow properties as 
shown in Table 9. 
3.7.2 Effervescent time 
Among all the formulations F2 Effervescent formulation 
possess effervescent time of 22 sec and was considered as 
optimum. Effervescent time of all the formulations is 
summarized in Table 10.  
 
 












F1 0.57 0.77 22.5 1.352 25.97 
F2 0.58 0.66 24.5 1.137 9.6 
F3 0.55 0.78 23.4 1.418 29.48 
F4 0.54 0.68 20.0 1.259 20.58 
F5 0.61 0.69 23.3 1.131 11.59 
F6 0.68 0.47 22.4 1.088 8.10 
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Table 10.  Effervescent time of different formulations 
Batches Effervescent times (Sec) 
F1 30 sec 
F2 22 sec 
F3 38 sec 
F4 24 sec 
F5 23 sec 
F6 25 sec 
 
3.7.3 Particle size analysis 
The particle size analysis showed maximum retention and was in the size range 1.40-1.70 mm for all the formulations as shown 
in Table 11. The mean diameter of the granules was found to be 1.40 mm approximately shown in fig 1. 
Table 11. Particle size analysis 
Sieve used Opening size (mm) Wt. retained (gm) % Retention 
4 4.75 0.0 0 
6 3.35 0.021 0.14 
8 2.36 0.749 4.996 
10 1.70 3.003 20.02 
12 1.40 9.558 63.72 
16 1.00 1.356 9.04 
20 0.85 0.192 1.28 
 
 
Fig 1. Graph plot of percentage retained 
 
3. 8 Evaluation parameters of fast dispersible granules 
Among fast dispersible granules formulations, having 
crosspovidone and sodium starch glycolate as super 
disintegrants exhibited long disintegration time, while in 
formulations having crosscarmellose showed fast 
disintegration as well as flow properties. Therefore, 
Crosscarmellose sodium was added as a super disintegrant. 
Formulation (F9) having crosscarmellose as super 
disintegrant showed remarkable results having angle of 
repose (26.2 Ѳ), bulk and tapped density with value 0.54 and 
0.71 respectively. On disintegration formulation F9 shows 
least disintegration time as compared to other formulation. 
The results are summarized in Table 12, 13 and Fig 2. 
 
 
Fig. 2 Disintegration time of fast dispersible formulation 
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Table 12. Evaluation parameters of fast dispersible granules 
Batch Bulk density (g/ml) Tapped density (g/ml) Angle of repose 
F1 0.51 0.64 32.8 
F2 0.58 0.66 33.4 
F3 0.62 0.64 42.1 
F4 0.56 0.68 29.6 
F5 0.59 0.64 33.2 
F6 0.60 0.69 31.5 
F7 0.58 0.65 32.6 
F8 0.55 0.60 28.2 
F9 0.54 0.71 26.2 
 
 
Table 13. Disintegration time of fast dispersible 
Batches Disintegration times (Sec) 
F1 303 sec 
F2 203 sec 
F3 210 sec 
F4 167 sec 
F5 160 sec 
F6 146 sec 
F7 73 sec 
F8 54 sec 
F9 52 sec 
 
Table 14. % Inhibition by standard (ascorbic acid) in 
DPPH assay 







Table 15. % Inhibition of DPPH by lyophilized amla juice 







Table 16. IC50 value of standard, fresh amla juice 
samples in DPPH assay 
Sample IC50 (µg/ml) ± S.D. 
Standard ascorbic acid 25.80±0.2 µg/ml 
Fresh amla juice 32 ±0.25 µg/ml 
 
3.9 Total phenolic content 
Total phenolic content of fresh amla juice was estimated, 
gallic acid used as standard. The results were depicted as 
8.94 mg GAE/100gm. 
3.10 Estimation of ascorbic acid and gallic acid in 
prepared formulation. 
Chromatogram of prepared formulations showed the 
presence of five peaks at deferent Rf, along with a peak each 
at Rf: 0.59 and 0.86 which were same for the standard 
ascorbic acid and gallic acid when applied in the same plate 
on different track. The chromatogram obtained from the 
optimized solvent system was illustrated in Fig.3 
 
Fig. 3: Calibration curve of gallic acid for estimation of 
total phenolic content 
3.11 Free radical scavenging activity (DPPH) 
The lyophilized amla juice powder showed promising free 
radical scavenging effect in a concentration dependent 
manner. The extracted amla juice showed more scavenging 
activity as compared to reference standards. The reduction 
of DPPH by the extracted amla juice was very high and the 
scavenging ability increased with increasing concentration 
as compared to the standard. Ascorbic acid was used as 
reference standard for antioxidant activity. The results are 
depicted in Table 14, Table 15 and Table 16. The IC50 value 
for the extracted amla juice and lyophilized amla juice are 
represented in fig 4 and fig 5. 
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Fig. 4 Standard curve for IC50 determination using ascorbic acid. 
 
Fig. 5 IC50 determination for lyophilized amla juice 
 
3.12 HPTLC Quantification and Estimation of Ascorbic 
acid and Gallic acid 
3.12.1 Optimization of mobile phase 
The optimized mobile phase containing Toluene: Ethyl 
acetate: Methanol: Formic acid (2:4:4:0.05 v/v/v) gave a 
sharp and well defined peak of ascorbic acid and gallic acid 
at Rf 0.59 and 0.86 after 20 minutes of chamber saturation. 
The chromatogram obtained from the optimized solvent 
system was illustrated in fig. 6.  
 
 
Fig. 6 Peak of standard ascorbic acid and gallic acid at Rf= 0.59 and 0.86 
 
Fig. 7 Calibration curve of standard (ascorbic acid and gallic acid) over a range of concentration from 400 –1400 ng, r2 
= 0.9 
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Fig. 8 Chromatogram of Lyophilized amla Powder 
 
Fig. 9  Chromatogram of amla effervescent granules 
 
Fig. 10 Chromatogram of amla dispersible granules 
 
3.13 Estimation of ascorbic acid and gallic acid in amla 
juice powder and formulations 
Chromatogram of amla juice powder and formulations 
showed the presence of seven peaks at different Rf along with 
a peak at Rf: 0.59 and 0.86 which were same for the standard 
ascorbic acid and gallic acid, when applied in the same plate 
on different track (Fig. 8-10). Spectra were found to be 
overlapped and the amount of ascorbic acid and gallic acid 
present in sample and formulations were evaluated. 
CONCLUSION 
The prepared formulations may be explored for 
development of a new range of herbal formulations with 
reproducible and stable characteristics. It is well 
documented that medicinal plants are natural gift to human 
lives to promote disease free healthy life. Amla is one of the 
precious gifts of nature to mankind. Hence it can be 
suggested to formulate effervescent and fast dispersible 
granules by incorporating the fruit extract of Emblica 
officinalis as an alternate of liquid herbal juices available in 
market. The effervescent formulations F2 and fast dispersible 
formulations F9 having croscarmellose as found to be 
optimum when evaluated on basis of their flow properties. 
Total phenolic content was determined and in vitro 
antioxidant activity was evaluated by DPPH assay. The 
content of ascorbic acid and gallic acid in lyophilized amla 
powder were estimated by HPTLC, so the portability and 
convenience of effervescent granules will dramatically 
increase patient compliance.  
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